Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model
Br J Cancer
.
2025 Jan;132(1):138.
doi: 10.1038/s41416-024-02918-x.
Authors
Y Kususda
1
,
H Miyake
2
,
M E Gleave
3
,
M Fujisawa
1
Affiliations
1
Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
2
Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
[email protected]
.
3
Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
PMID:
39627565
PMCID:
PMC11724106
(available on
2025-12-03
)
DOI:
10.1038/s41416-024-02918-x
No abstract available
Publication types
Expression of Concern